about
sameAs
Brain delivery of proteins via their fatty acid and block copolymer modificationsEffect of the physicochemical properties of poly(ethylene glycol) brushes on their binding to cellsPEGylated helper-dependent adenoviral vectors: highly efficient vectors with an enhanced safety profile.Polymeric nanomedicine for cancer MR imaging and drug deliveryNanopharmaceuticals (part 1): products on the market.NANOMATERIALS FOR PROTEIN MEDIATED THERAPY AND DELIVERY.Argininosuccinate synthetase (ASS) deficiency in high-grade pulmonary neuroendocrine carcinoma: an opportunity for personalized targeted therapy.In Vivo Remote Control of Reactions in Caenorhabditis elegans by Using Supramolecular Nanohybrids of Carbon Nanotubes and Liposomes.Multifunctional synthetic poly(L-glutamic acid)-based cancer therapeutic and imaging agents.Design of non-standard insulin analogs for the treatment of diabetes mellitusPolymers for gene delivery across length scales.Polymer conjugates as anticancer nanomedicines.Polymer therapeutics--polymers as drugs, drug and protein conjugates and gene delivery systems: past, present and future opportunities.Nanotechnology for targeted cancer therapy.Biomedical interfaces: titanium surface technology for implants and cell carriers.Drug delivery technologies for autoimmune disease.Micelle-like nanoassemblies based on polymer-drug conjugates as an emerging platform for drug delivery.PEGylated nanomedicines: recent progress and remaining concerns.Nanoparticulate carriers: an emerging tool for breast cancer therapy.PEGylation and its impact on the design of new protein-based medicines.Polymer therapeutics at a crossroads? Finding the path for improved translation in the twenty-first century.Bioanalytical approaches to assess the proteolytic stability of therapeutic fusion proteins.Biointerfacing and Applications of Cell Membrane-Coated Nanoparticles.Materials and methods for delivery of biological drugs.S-layer fusion protein as a tool functionalizing emulsomes and CurcuEmulsomes for antibody binding and targeting.Poly(2-oxazoline) hydrogels as next generation three-dimensional cell supportsPurification and analysis of mono-PEGylated HSA by hydrophobic interaction membrane chromatography.Evolution and Clinical Translation of Drug Delivery Nanomaterials.Antimicrobial Peptides: Diversity, Mechanism of Action and Strategies to Improve the Activity and Biocompatibility In Vivo.Lessons in simplicity that should shape the future of drug delivery.Quantification of Paclitaxel and Polyaspartate Paclitaxel Conjugate in Beagle Plasma: Application to a Pharmacokinetic Study.Magnetically and Near-Infrared Light-Powered Supramolecular Nanotransporters for the Remote Control of Enzymatic Reactions.Calprotectin Pegylation Enhanced Its Physical and Structural Properties.Charge-conversional and pH-sensitive PEGylated polymeric micelles as efficient nanocarriers for drug delivery.Site-specific PEGylation of an anti-CEA/CD3 bispecific antibody improves its antitumor efficacy.Biosynthetic-Synthetic Polymer ConjugatesProduction of PEGylated ProteinsControlled-release formulation of perindopril erbumine loaded PEG-coated magnetite nanoparticles for biomedical applications
P2860
Q30354932-FB810DD3-6527-4151-B767-F86FD2E41A29Q33282118-50B338B1-FDA3-4726-A667-3AF462BCB5C0Q33364520-C32C360F-3BAC-4B3F-B9A0-70CF01C06263Q33773418-FF3F9E5C-004B-46F0-9DA5-79CD35E005B6Q34230175-498D3BF3-66F6-4D0D-BF14-C368F407D3A8Q34534023-A095F0D0-03F0-458E-AB4F-7AA410836047Q35535519-E0B685BD-AA7C-4047-A175-F2D75CCCFC53Q35682204-88F52F28-507F-4014-877D-809F20E6D1C2Q36214907-F6E4533F-6D10-401B-B98C-13F386EF1189Q36374363-9175D679-4322-4B04-A245-BCB99925A82CQ36494142-A3F56DBE-8C93-4630-9B75-B03BA1EEBB1BQ36561667-429BAEED-B22A-4B4D-877D-5C3C1DB54BDFQ36648444-D33110D8-08DF-45EE-830C-4959768402D8Q36842770-641C5010-16BE-4C6F-97B3-054A86C27DF8Q36917982-76E21645-1E36-4D02-B316-7CBED6091170Q37801381-517FEC4B-8258-4A0E-8D1D-CC4595CDBBC4Q38011258-8464D011-39F2-4AC9-98FF-8383E8C284A7Q38167826-17D83922-8F74-4420-AF97-F1AB607E43C4Q38250517-56EB68F4-2EDB-4582-86C0-98150D1EE285Q38269324-1D8F01B5-C8F8-43E1-AC54-C80CD4A15700Q38645927-BDFFA012-9553-4576-A32F-C253655ABCF4Q38652655-89F7DC88-E105-4242-B17E-172A4601F771Q38734878-9E9BD7B0-A7FE-4F73-A22C-B7B4EB95EBE2Q38987392-DAB4CCC4-7ADF-41CE-8CDF-6EE731A1409AQ39873136-4849A007-6E19-4EEC-88D0-7858893FB6F7Q40456028-E70B032E-CE11-45D1-9E46-ABD2F0C4F0E5Q44970118-9F1C0A28-F94D-440B-8EA9-12443335482CQ47263594-4B5BB9B9-0572-4131-B94D-A6A3E2D0A8BDQ47723258-8F6EE49F-CACA-4739-BA30-582F8CFBFB06Q48361564-9413198D-1E99-47F3-ACC9-6E110C495643Q51307074-139CF6A7-91E1-4AD8-90E2-BE1528B142E1Q51371022-71836F60-5B87-4D2E-B11B-9541952985D8Q51376933-B0AFA45B-BCC4-4055-AD13-62892FA8CAC8Q53540613-C770B496-E711-4945-8BAD-08253F64063EQ55021294-BD6AF230-F8BC-4450-8288-652EAD8D3A95Q57373258-E9AA5018-7FEF-45C9-B463-707176C622BCQ57635944-00A50F03-2F56-41E9-8D72-99107D8FA664Q59318878-83D7D08A-C27E-4923-90B6-EF160C168D37
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The origin of pegnology
@ast
The origin of pegnology
@en
The origin of pegnology
@nl
type
label
The origin of pegnology
@ast
The origin of pegnology
@en
The origin of pegnology
@nl
prefLabel
The origin of pegnology
@ast
The origin of pegnology
@en
The origin of pegnology
@nl
P1476
The origin of pegnology
@en
P2093
Frank F Davis
P356
10.1016/S0169-409X(02)00021-2
P407
P577
2002-06-17T00:00:00Z